Inverse agonist properties of N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide HCl (SR141716A) and 1-(2-chlorophenyl)-4-cyano-5-(4-methoxyphenyl)-1H-pyrazole-3-carboxylic acid phenylamide (CP-272871) for the CB1 cannabinoid receptor

This publication has 20 references indexed in Scilit:

• SR141716A, a potent and selective antagonist of the brain cannabinoid receptor
  Published by Wiley ,2001
• Inverse agonism: pharmacological curiosity or potential therapeutic strategy?
  Published by Elsevier ,2000
• Potential Biosynthetic Connections between the Two Cannabimimetic Eicosanoids, Anandamide and 2-Arachidonoyl-Glycerol, in Mouse Neuroblastoma Cells
  Biochemical and Biophysical Research Communications, 1996
• Two novel classes of neuroactive fatty acid amides are substrates for mouse neuroblastoma ‘anandamide amidohydrolase’
  FEBS Letters, 1995
• Endogenous ligands and inverse agonism
  Trends in Pharmacological Sciences, 1995
• Pharmacology of Cannabinoid Receptors
  Annual Review of Pharmacology and Toxicology, 1995
• Precoupling of GiGo-linked receptors and its allosteric regulation by monovalent cations
  Life Sciences, 1993
• Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
  Science, 1992
• Reverse intrinsic activity of antagonists on G protein-coupled receptors
  Trends in Pharmacological Sciences, 1992
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
  Analytical Biochemistry, 1976